OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1 mg/mL pump actuated metered dose aerosol (reformulation), GlaxoSmithKline Consumer Healthcare Australia Pty Ltd, CON-885
Product name
OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1 mg/mL pump actuated metered dose aerosol (reformulation)
Sponsor name
GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
Consent start
Consent no.
CON-885
Duration
The consent is effective from 25 November 2021 until 26 November 2023.
Standard
Subparagraph 11(2)(f)(i) of Therapeutic Goods Order No. 92 - Standard for labels of non-prescription medicines (TGO 92)
Non-compliance with standard
The products do not conform to the requirements of subparagraph 11(2)(f)(i) of
Therapeutic Goods Order No. 92 Standard for labels of non-prescription medicines
(TGO 92) in that the medicine labels express the quantity of the active
ingredient as weight per volume instead of quantity delivered per actuation.
Therapeutic product type
Other therapeutic goods registered